Gilde Healthcare IV Management B.V., 10% Owner at Axonics Modulation Technologies, Inc. (AXNX), bought 3,133,332 shares at $15.00 ($13.0M) on 2018-11-02, disclosed to the SEC on 2018-11-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,266,666 | $0 | 0.0% |
| 2 | $15.00 | 866,666 | $13.0M | 100.0% |
| Total | $4.15 avg | 3,133,332 | $13.0M | 100% |
| Filing → |